Haffner retiring from FDA to join Amgen

Share this article:
The FDA's director of orphan products development for the past 19 years, Marlene Haffner, will retire in January to join the biotech firm Amgen as director of its government affairs office in Washington.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions